Infant mortality is one of the important indicators of development in different countries, which earnestly try to reduce infant mortality and increase the quality of life of this vulnerable group (
1,
2). Currently, neonates are clinically examined by physicians after birth, especially in terms of cardiovascular health, including the presence of patent ductus arteriosus (PDA) (
3). The fetal artery duct connects the pulmonary artery and the descending aorta, through which oxygen-free blood returns to the right heart and then is directed to the placenta (
4,
5).
Gestational age at labor is inversely related to the spontaneous closure of the ductus arteriosus (DA). Approximately 65% of neonates born between 25 and 28 weeks of gestation and 85% of neonates born in a gestational age of 24 weeks present with PDA in their first week of life (
5,
6). In full-term infants, arterial duct naturally contracts after birth, which is stimulated by a rapid increase in arterial oxygen pressure because the DA muscle layer is sensitive to oxygen. It is gradually closed and is eventually transformed into a fibrous non-functional tissue until up to four days after birth; however, anatomically, it may take up to one week after birth for the arterial duct to become closed (
7).
Patent ductus arteriosus murmurs are heard more frequently and for longer periods in preterm infants and are typically associated with respiratory distress syndrome (RDS) (
7). Various factors such as excessive intravenous fluids, corticosteroids, and prematurity of the infant cause can delay the closure of the arterial canal, leaving it to remain opened longer, disturbing the pulmonary artery and leading to PDA clinical symptoms (
7,
8).
Untreated PDA can be associated with side effects such as prolonged mechanical ventilation, bronchopulmonary dysplasia (BPD), pulmonary hemorrhage, necrotizing enterocolitis (NEC), renal failure, intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL), cerebral palsy, and even death (
8,
9). Due to significant complications of PDA, most infants born to mothers with a gestational age of fewer than 28 weeks will need medical interventions (
10). Gold standard for the diagnosis of PDA is cardiac doppler echocardiography, which should be performed by a pediatric cardiologist to accurately detect blood flow through the duct during the cardiac cycle (
6,
11).
Echocardiography is the method of choice to diagnose, treat, and follow up neonates with heart diseases. Due to the relatively high cost of the procedure, finding alternative methods is seriously pursued by researchers so that these patients can be diagnosed and monitored in centers with limited facilities (
6,
12-
14).
Perfusion index (PI) is a non-invasive measure obtained by a pulse oximetry device (
15,
16). In recent years, studies have shown that PI can help diagnose some neonatal heart diseases, such as coarctation cases missed by pulse oximetry (
17). However, no study has been performed in Iran to evaluate the relationship between PI and PAD.